Article in Journal

Identification of a novel score for adherence to the mediterranean diet that is inversely associated with visceral adiposity and cardiovascular risk: the chrono med diet score (CMDS)

De Matteis, C., Crudele, L., Battaglia, S., Loconte, T., Rotondo, A., Ferrulli, R., Gadaleta, R. M., Piazzolla, G., Suppressa, P., Sabbà, C., Cariello, M & Moschetta, A.

Nutrients, 2023, 15(8),1910

OPEN ACCESS

April 15, 2023


Related to

  1. Home

     / 
  2. Research outputs

     / 
  3. Identification of a novel score for adherence to the mediterranean die...

Adherence to the Mediterranean diet (MedDiet) leads to reduction of mortality from all causes, especially in subjects with cardiovascular disease, obesity, and diabetes. Numerous scores have been proposed to evaluate the adherence to MedDiet, mainly focused on eating habits. In this study, we verified whether existing validated MedDiet scores, namely, MEDI-LITE and the Mediterranean Diet Score (MDS), could be associated with visceral adiposity. Failing to find a significant association with adiposity, we proposed the validation of a new, easy-to-use adherence questionnaire, the Chrono Med-Diet score (CMDS). CMDS contains eleven food categories, including chronobiology of dietary habits and physical activity. Compared to the MEDI-LITE score and MDS, low values of CMDS are linked to increased waist circumference (WC) and dysmetabolic conditions. CMDS was also inversely correlated with cardiovascular risk (CVR), as well as Fatty Liver Index (FLI). In conclusion, the CMDS is a novel questionnaire to study the adherence to the MedDiet that, focusing on type and timing of carbohydrates intake, has the peculiar capability of capturing subjects with abdominal obesity, thus being an easy-to-use instrument of personalized medicine.

This research output is related to

Spoke 04

Food quality and nutrition

To push towards sustainable and tailored food and nutrition

Lead organisationUniMi

Spoke leaderPatrizia Riso
Research projectOMI_MET

Nutri-omics signatures in mets patients


Managed by


Principal investigators

Antonio Moschetta,Marialisa Clodoveo,Maria Calasso,Gaetano Villani

Referred to

Spoke 04